- Transcatheter aortic valve implantation (TAVI) is a key treatment for aortic stenosis in older patients with high surgical risks.
- TAVI has been shown to be non-inferior to surgical valve replacement in intermediate-risk patients, leading to an increase in potential TAVI candidates.
- Concerns about the higher costs of TAVI are balanced by shorter hospital stays and lower complication costs.
- Studies highlight the importance of proper patient selection for TAVI, especially in cases of degenerative mitral regurgitation (MR) alongside aortic stenosis.
- Pre-operative degenerative MR can impact postoperative prognosis after TAVI, emphasizing the need for accurate patient stratification to improve outcomes.
Source link
Cardiology,Pulmonary Medicine,Internal Medicine